Doris Lanz
0000-0001-9879-3069
21 papers found
Refreshing results…
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: Efficacy, quality-of-life and toxicity
Missing publications? Search for publications with a matching author name.